Close X
Attorney Spotlight

Find out which two countries Cheryl Palmeri gets the most questions about related to International Trade in today's market? Find out more>


Close X


Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

Quorum Spinoff Deal Recognized as Finalist by 15th Annual M&A Advisor Awards

August 29, 2016

Nashville, Tenn., (August 29, 2016) - The M&A Advisor is pleased to announce the Finalists in the categories of M&A Deal of the Year, Restructuring Deal of the Year, Cross-Border Deal of the Year, Corporate/Strategic Acquisition of the Year, Deal Financing of the Year, Sector Deals of the Year, Firms of the Year, M&A Product/Service of the Year and M&A Professionals of the Year for the 15th Annual M&A Advisor Awards.

Bass, Berry & Sims was recognized as a Finalist as part of the deal team involving the "Spinoff of Quorum Health Corporation" in the following categories:

  • Healthcare and Life Sciences Deal of the Year (over $100MM)
  • Restructuring Deal of the Year (over $100MM)
  • Corporate and Strategic Acquisition Deal of the Year (over $500MM)
  • M&A Deal of the Year (over $1 billion - $5 billion)

The Finalists have been selected from the nominees in the first stage of evaluation, and the independent panel of judges will now focus their attention on the challenging task of selecting the ultimate award winners that will be announced at the Awards Gala on Wednesday, November 9 in New York - the premier celebration of the year for firms and professionals in the M&A industry. Held in conjunction with the Annual M&A Advisor Summit, the Gala will bring together the industry's leaders, vying for the 2016 Awards, to celebrate the Finalists and Winners.

The M&A Advisor
The M&A Advisor was founded in 1998 to offer insights and intelligence on mergers and acquisitions through the industry's leading publication. Today, the firm is recognized as the world's premier "think tank" and leadership organization for m&a, restructuring and financing professionals, providing a range of integrated services including: M&A Advisor Forums and Summits; M&A Advisor Market Intelligence; M&A.TV.; M&A Advisor Live; M&A Advisor Awards; and M&A Advisor Connects. For additional information about The M&A Advisor's leadership services visit

About Bass, Berry & Sims PLC
With more than 260 attorneys representing numerous publicly traded companies and Fortune 500 businesses, Bass, Berry & Sims has been involved in some of the largest and most significant litigation matters and business transactions in the country. For more information, visit

Related Professionals

Related Services


Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.